NJ ACTS is committed to advancing clinical and translational research to develop new therapies and preventive approaches in order to improve health and health care in New Jersey. The Clinical and Translational Research Pilot Program offers one-year pilot grants to investigators from Princeton University, Rutgers University, New Jersey Institute of Technology (NJIT) and RWJBarnabas Health. The program offers pilot grants up to $100,000 to develop and advance innovative clinical and translational research, provide a path to sustainable, extramurally-funded independent research, and encourage the development of innovations with the potential for commercialization. All pilot research projects must demonstrate clinical relevance.
2024 Pilot Program Letter of Intent and Application Deadlines - November 4 (required) and December 13
The pilot grant program is seeking three categories of proposals:
- Clinical and Translational Research Projects
- PROPEL Projects
- Valued Partnership Projects
To learn more, review the 2024 Pilot Program Request for Applications.
View a list of all NJ ACTS Pilot Grants awarded.
Congratulations to the 2021 and 2022 Awardees from Princeton - Alexander Ploss (MOL), Cameron Myhrvold (MOL), Nathaniel Daw (PNI), Celeste Nelson (CBE), Mohamed Donia (MOL), Sabine Petry (MOL), Danelle Devenport (MOL) and Tim Buschman (PNI).
Previous awardees from 2019-2020 were Howard Stone (MAE), Andrea Graham (EEB), Jonathan Cohen (PNI), Daniel Notterman (MOL), Zemer Gitai (MOL), Esteban Engel (PNI), Catherine Peña (PNI), and Kathryn Edin (SOC/SPIA).
Sign up for our interest list to receive updates and the latest information about the pilot grant program funding opportunity.